Publications of Julia Sacher

Sacher, J., Wilson, A. A., Houle, S., Rusjan, P., Hassan, S., Bloomfield, P. M., … Meyer, J. H. (2010). Elevated brain monoamine oxidase A binding in early postpartum period. Archives of General Psychiatry, 67, 468–474.

Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., & Müller, K. (2010). Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology, 2010. doi:10.1155/2010/780645

Kasper, S., Sacher, J., Klein, N., Mossaheb, N., Attarbaschi-Steiner, T., Lanzenberger, R., … Dudczak, R. (2009). Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology, 24, 119–125.

Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., … Houle, S. (2009). Brain monoamine oxidase a binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery and recurrence. Archives of General Psychiatry, 66, 1304–1312.

Sacher, J., Mossaheb, N., Spindelegger, C., Klein, N., Geiss-Granadia, T., Sauermann, R., … Kasper, S. (2008). Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology, 33, 1633–1641.

Attarbaschi, T., Sacher, J., Geiss-Granadia, T., Klein, N., Mossaheb, N., Lanzenberger, R., … Tauscher, J. (2007). Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol, 17, 102–7.

Klein, N., Sacher, J., Geiss-Granadia, T., Mossaheb, N., Attarbaschi, T., Lanzenberger, R., … Kasper, S. (2007). Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology, 191, 333–9.

Lanzenberger, R., Mitterhauser, M., Spindelegger, C., Wadsak, W., Klein, N., Mien, L.-K., … Tauscher, J. (2007). Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry, 61, 1081–9.

Sacher, J., Asenbaum, S., Klein, N., Geiss-Granadia, T., Mossaheb, N., Poetzi, C., … Tauscher, J. (2007). Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand. Int J Neuropsychopharmacol, 10, 211–8.

Klein, N., Sacher, J., Geiss-Granadia, T., Attarbaschi, T., Mossaheb, N., Lanzenberger, R., … Kasper, S. (2006). In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology, 188, 263–72.

Sacher, J., Weigl, L., Werner, M., & Hohenegger, M. (2005). Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther., 31, 1032–41.

Klein , N., Sacher, J., Wallner, H., Tauscher, J., & Kasper, S. (2004). Therapy of treatment resistant depression: Focus on the management of TRD with atypical antipsychotics. CNS Spectrums, 9, 823–832.

Werner, M., Sacher, J., & Hohenegger, M. (2004). Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol., 143, :715–24.

Zsido, R., & Sacher, J. (2021). Time to rethink the default settings in neuroscience: Hormonal transition periods as natural experiments and why sex matters. In U. Weber (Ed.), Fundamental questions: Gender dimensions in Max Planck research projects (pp. 27–42). Baden-Baden: Nomos.

Sacher, J. (2017). Die Rolle von hormonellen Übergangsphasen für Geschlechtsunterschiede in der psychischen Gesundheit. In K. Stengler (Ed.), Genderperspektiven in der Medizin (GPmed): Abstractband zur Tagungsreihe an der Universität Leipzig (pp. 64–65). Leipzig: Pöge.

Hoffmann, K. C., Zsido, R., Villringer, A., Engert, V., & Sacher, J. (2024). Stress markers and brain structure in premenstrual dysphoric disorder and health across the menstrual cycle. In Neuropsychopharmacology (Vol. 49, pp. 373–374). New York, NY: Springer Nature.

Endres, K., Lammer, L., Wittekind, D., Riedel-Heller, S. G., Sacher, J., Villringer, A., & Witte, A. V. (2023). Obesity and depressive symptoms: Investigating the mediating role of fasting ghrelin serum levels. In Neuroscience Applied (Vol. 2). Amsterdam, The Netherlands: Elsevier. doi:10.1016/j.nsa.2023.102798

Zsido, R., Williams, A. N., Barth, C., Serio, B., Kurth, L., Beyer, F., … Sacher, J. (2022). Menstrual cycle brain plasticity: Ultra-high field 7 T MRI reveals changes in human medial temporal lobe volume in female adults. In Neuropsychopharmacology (Vol. 47, pp. 241–242). New York, NY: Springer Nature.

Schaadt, G., Zsido, R., Friederici, A. D., Villringer, A., Obrig, H., Männel, C., & Sacher, J. (2021). Association of maternal mood postpartum with electroencephalography patterns of infant speech development at 2 and 6 months. In Neuropsychopharmacology (Vol. 46, pp. 144–145). New York, NY: Springer Nature.

Beinhölzl, N., Molloy, E., Zsido, R., Richter, T., Piecha, F. A., Zheleva, G., … Sacher, J. (2021). One-week of escitalopram administration does not change emotional and attentional responses in healthy female individuals on oral hormonal contraceptives. In European Neuropsychopharmacology (Vol. 53, pp. S603–S604). Amsterdam: Elsevier.